MKVentures Capital Q3 FY26: Sharp Revenue Decline Triggers Profit Slump

Feb 13 2026 01:56 PM IST
share
Share Via
MKVentures Capital Ltd., a Mumbai-based micro-cap non-banking financial company, reported a concerning third quarter for FY2026, with net profit plunging 56.77% year-on-year to ₹2.33 crores from ₹5.39 crores in Q3 FY25. The sequential decline was equally troubling, with profits dropping 33.62% from Q2 FY26's ₹3.51 crores. The company, which trades at ₹970.00 with a market capitalisation of ₹363.00 crores, has witnessed its stock price decline 37.49% over the past year, significantly underperforming the Sensex's 8.73% gain during the same period.
MKVentures Capital Q3 FY26: Sharp Revenue Decline Triggers Profit Slump
Net Profit (Q3 FY26)
₹2.33 Cr
▼ 56.77% YoY
Net Sales (Q3 FY26)
₹3.56 Cr
▼ 54.71% YoY
PAT Margin
132.39%
▲ 23.06 ppts YoY
ROE (Average)
13.46%
Latest: 7.13%

The revenue collapse proved the primary catalyst for the profit decline, with net sales crashing 54.71% year-on-year to ₹3.56 crores in Q3 FY26 from ₹7.86 crores in the corresponding quarter last year. On a sequential basis, sales fell 41.35% from Q2 FY26's ₹6.07 crores. This sharp contraction in top-line growth has raised concerns about the company's business model sustainability and competitive positioning within the NBFC sector.

Financial Performance: Revenue Erosion Dominates Narrative

The quarterly trend reveals a troubling pattern of revenue volatility and declining profitability. For Q3 FY26, net sales stood at ₹3.56 crores, representing a dramatic 54.71% year-on-year decline. The sequential contraction of 41.35% from Q2 FY26 further underscores the severity of the revenue challenge. This marks the lowest quarterly sales figure in recent quarters, falling below even the ₹2.88 crores reported in Q4 FY25.

Quarter Net Sales (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change PAT Margin
Dec'25 (Q3) 3.56 -41.35% 2.33 -33.62% 132.39%
Sep'25 (Q2) 6.07 +0.66% 3.51 -18.18% 204.07%
Jun'25 (Q1) 6.03 +109.38% 4.29 -180.94% 137.06%
Mar'25 (Q4) 2.88 -63.36% -5.30 -198.33% -105.58%
Dec'24 (Q3) 7.86 +15.25% 5.39 +27.12% 109.33%
Sep'24 (Q2) 6.82 -10.85% 4.24 -17.99% 70.67%
Jun'24 (Q1) 7.65 5.17 138.61%

Operating profit before depreciation, interest, and tax (excluding other income) declined to ₹2.44 crores in Q3 FY26, down from ₹7.37 crores in Q3 FY25, though the operating margin expanded to 138.64% from 149.49%. The margin improvement, however, appears misleading given the absolute revenue decline. Interest costs decreased to ₹0.27 crores from ₹0.83 crores year-on-year, providing some relief to the bottom line. Tax expenses collapsed to just ₹0.02 crores, representing an unusually low tax rate of 0.85% compared to 25.07% in Q3 FY25, which artificially supported net profit margins.

Critical Revenue Warning

The company's net sales for the first nine months of FY2026 stand at ₹15.66 crores, down significantly from prior periods. With Q3 FY26 showing the sharpest quarterly decline yet, the trajectory suggests fundamental business challenges rather than temporary headwinds. The operating profit margin of 138.64%, whilst appearing strong, is distorted by the extremely low revenue base and cannot mask the underlying revenue erosion.

Balance Sheet Concerns: Investment Surge Raises Questions

Examining the balance sheet as of March 2025, shareholder funds stood at ₹102.89 crores, comprising ₹3.84 crores in share capital and ₹99.05 crores in reserves. The company maintains a debt-free status with zero long-term debt, which provides financial flexibility but also raises questions about growth capital deployment. Current assets increased to ₹79.51 crores from ₹45.76 crores, whilst current liabilities rose to ₹56.65 crores from ₹38.00 crores.

A notable development in the balance sheet is the dramatic surge in investments to ₹73.02 crores in FY25 from just ₹12.19 crores in FY24. This represents a nearly six-fold increase in investment holdings, raising questions about the company's strategic direction and whether these investments are generating adequate returns. Fixed assets remained relatively stable at ₹15.14 crores. The return on equity (ROE) has deteriorated to 7.13% in the latest period from an average of 13.46%, indicating declining capital efficiency.

Cash Flow Analysis: Operating Strength Offset by Investment Outflows

The cash flow statement for FY25 reveals a complex picture. Operating cash flow stood strong at ₹33.00 crores, driven by profit before tax of ₹13.00 crores and favourable working capital changes of ₹17.00 crores. However, investing activities consumed ₹62.00 crores, primarily reflecting the significant increase in investment holdings. Financing activities showed a modest outflow of ₹1.00 crores. The net result was a cash outflow of ₹30.00 crores, with closing cash declining to effectively zero from ₹31.00 crores in the prior year.

Investment Strategy Under Scrutiny

The company's decision to deploy ₹62.00 crores into investments during FY25, whilst simultaneously experiencing revenue contraction, warrants careful monitoring. With cash reserves depleted and revenue declining sharply in recent quarters, the sustainability of this investment-heavy strategy remains questionable. Investors should closely track whether these investments generate sufficient returns to justify the opportunity cost and cash consumption.

Peer Comparison: Valuation Premium Unjustified by Fundamentals

When benchmarked against NBFC sector peers, MKVentures Capital's valuation metrics appear stretched relative to its operational performance. The company trades at a price-to-earnings ratio of 47.50x, significantly higher than the industry average of 23x and substantially above most direct peers. The price-to-book ratio of 3.39x also commands a premium, particularly concerning given the declining ROE trend.

Company P/E (TTM) P/BV ROE (%) Div Yield (%) Debt/Equity
MKVentures Capital 47.50 3.39 13.46 0.02 0.00
Nahar Capital 6.35 0.26 6.57 0.60 0.00
UVS Hospitality 30.54 2.59 8.47 0.02
Unifinz Capital 5.70 3.63 20.12 0.08 1.13
Avonmore Capital 29.76 1.10 18.18 0.07
Delphi World 22.23 1.62 7.28 0.05

MKVentures Capital's ROE of 13.46% places it in the middle of the peer group, though recent quarterly performance shows deterioration to 7.13%. More concerning is the company's dividend yield of just 0.02%, the lowest among peers, offering minimal income support to shareholders. The debt-free status matches several peers but provides limited differentiation. Given the revenue challenges and declining profitability, the valuation premium appears difficult to justify on fundamental grounds.

Valuation Analysis: Expensive by All Metrics

The company's current valuation assessment grades it as "Very Expensive" based on historical and peer comparisons. Trading at 47.50 times trailing twelve-month earnings, MKVentures Capital commands a significant premium to the NBFC sector average of 23x. The enterprise value-to-EBITDA multiple of 33.03x and EV-to-sales ratio of 16.15x further underscore the stretched valuation.

The price-to-book value of 3.39x appears particularly elevated given the company's 13.46% average ROE and current ROE of just 7.13%. For context, a company with 7.13% ROE typically warrants a P/BV ratio closer to 0.7x-1.0x, suggesting the current valuation implies expectations of dramatic operational improvement that recent quarterly results fail to support. The stock trades at ₹970.00, down 48.68% from its 52-week high of ₹1,890.05 but still 9.73% above its 52-week low of ₹884.00.

Valuation Metric Current Value Assessment
P/E Ratio (TTM) 47.50x Premium to sector (23x)
Price to Book Value 3.39x Elevated for ROE profile
EV/EBITDA 33.03x Expensive
EV/Sales 16.15x Very high multiple
Dividend Yield 0.02% Negligible income support

Shareholding Pattern: Stable but Limited Institutional Interest

The shareholding structure has remained remarkably stable over the past five quarters. Promoter holding stands firm at 74.36% with no sequential changes, indicating strong promoter commitment but also limited float for public investors. Foreign institutional investor (FII) holding remains at 4.26%, whilst mutual fund, insurance, and other domestic institutional investor holdings remain at zero.

Shareholder Category Dec'25 Sep'25 Jun'25 Mar'25 QoQ Change
Promoter 74.36% 74.36% 74.36% 74.36% 0.00%
FII 4.26% 4.26% 4.26% 4.26% 0.00%
Mutual Funds 0.00% 0.00% 0.00% 0.00% 0.00%
Insurance 0.00% 0.00% 0.00% 0.00% 0.00%
Other DII 0.00% 0.00% 0.00% 0.00% 0.00%
Non-Institutional 21.38% 21.38% 21.38% 21.38% 0.00%

The complete absence of mutual fund and insurance company participation signals limited institutional confidence in the company's prospects. With total institutional holdings at just 4.26%, the stock lacks the institutional support typically associated with quality mid-cap and small-cap investments. The stable shareholding pattern, whilst indicating no panic selling, also suggests no fresh institutional interest despite the stock's 37.49% decline over the past year.

Stock Performance: Severe Underperformance Across Timeframes

The stock's performance metrics paint a concerning picture across virtually all timeframes. Over the past year, MKVentures Capital has declined 37.49% whilst the Sensex gained 8.73%, resulting in a negative alpha of 46.22 percentage points. The three-year performance shows a 32.11% decline against the Sensex's 36.99% gain, representing underperformance of 69.10 percentage points.

Period Stock Return Sensex Return Alpha
1 Week 2.22% -0.95% +3.17%
1 Month -4.79% -1.00% -3.79%
3 Months -24.87% -2.00% -22.87%
6 Months -37.64% 2.79% -40.43%
YTD -9.06% -2.86% -6.20%
1 Year -37.49% 8.73% -46.22%
2 Years -34.30% 15.70% -50.00%
3 Years -32.11% 36.99% -69.10%

The technical picture reinforces the bearish fundamental outlook. The stock trades below all major moving averages, including the 5-day (₹979.02), 20-day (₹985.13), 50-day (₹1,032.09), 100-day (₹1,188.48), and 200-day (₹1,395.74) moving averages. The overall technical trend remains "Bearish" since August 21, 2025. With a high beta of 1.50, the stock exhibits 50% more volatility than the broader market, amplifying both gains and losses. The risk-adjusted return of -0.94 over the past year, combined with 39.91% volatility, classifies the stock as "High Risk Low Return."

"A micro-cap NBFC trading at 47.50x earnings with declining revenues, deteriorating ROE, and no institutional support presents a challenging risk-reward proposition for investors."

Investment Thesis: Multiple Red Flags Outweigh Limited Positives

The investment case for MKVentures Capital faces significant headwinds across multiple dimensions. The company's proprietary score of just 17 out of 100 reflects the confluence of negative factors: bearish technical trend, negative financial trend, weak fundamental strength with an average ROE of 13.46%, and consistent underperformance against benchmarks over three years. The quality grade of "Below Average" and valuation assessment of "Very Expensive" further compound the concerns.

KEY STRENGTHS

  • Debt-free balance sheet with zero long-term borrowings
  • Stable promoter holding at 74.36% with no pledging
  • Strong operating cash flow generation of ₹33.00 crores in FY25
  • High PAT margins despite revenue challenges
  • Low interest burden with costs declining to ₹0.27 crores

KEY CONCERNS

  • Revenue collapsed 54.71% YoY in Q3 FY26 to ₹3.56 crores
  • Net profit declined 56.77% YoY to ₹2.33 crores
  • ROE deteriorated to 7.13% from 13.46% average
  • Trading at expensive 47.50x P/E despite weak fundamentals
  • Zero mutual fund and insurance participation
  • Stock down 37.49% over past year with high volatility
  • Negative financial trend with declining sales momentum

Outlook: Critical Monitoring Points for Stakeholders

Looking ahead, investors must closely monitor several critical factors that will determine whether MKVentures Capital can stabilise its business and justify its premium valuation. The immediate priority is arresting the revenue decline and demonstrating sustainable top-line growth. The company's heavy investment in financial assets totalling ₹73.02 crores must begin generating visible returns to validate the capital allocation strategy.

POSITIVE CATALYSTS

  • Stabilisation of revenue with positive QoQ growth
  • Return on investments portfolio exceeding 15%
  • ROE improvement back above 13% levels
  • Entry of institutional investors (MF/insurance)
  • Consistent quarterly profitability above ₹4 crores

RED FLAGS

  • Further revenue decline below ₹3 crores quarterly
  • Cash depletion requiring debt funding
  • ROE falling below 5% levels
  • Promoter stake reduction or pledging
  • Quarterly losses or sustained margin compression

The company's ability to navigate the current challenges will likely determine its long-term viability. With limited institutional support, expensive valuation, and deteriorating fundamentals, the margin for error appears minimal. Shareholders should demand clear communication on the revenue strategy, investment portfolio performance, and path to sustainable profitability improvement.

The Verdict: Exit Recommended

STRONG SELL

Score: 17/100

For Fresh Investors: Avoid initiating positions. The combination of deteriorating fundamentals (revenue down 54.71% YoY, ROE at 7.13%), expensive valuation (47.50x P/E), bearish technical trend, and zero institutional participation presents an unfavourable risk-reward profile. Better opportunities exist in the NBFC space with stronger growth trajectories and reasonable valuations.

For Existing Holders: Consider exiting positions on any technical bounce. The stock has declined 37.49% over the past year and shows no signs of fundamental stabilisation. With the financial trend remaining negative and valuation still expensive despite the price correction, holding carries significant downside risk. The absence of institutional support limits potential for sharp recovery.

Fair Value Estimate: ₹650-700 (29-32% downside from current levels), implying a more reasonable 30-35x P/E multiple aligned with the company's deteriorating fundamentals and below-average quality profile.

Note— ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News